TrialThe Lancet. Microbe2022

Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial.

Will Stone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.